Star Combo Pharma Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Su Zhang
Chief executive officer
AU$196.3k
Total compensation
CEO salary percentage | 86.6% |
CEO tenure | 6.2yrs |
CEO ownership | 8.5% |
Management average tenure | no data |
Board average tenure | 6.1yrs |
Recent management updates
Recent updates
Star Combo Pharma Limited's (ASX:S66) Shares May Have Run Too Fast Too Soon
Mar 20Should Shareholders Have Second Thoughts About A Pay Rise For Star Combo Pharma Limited's (ASX:S66) CEO This Year?
Nov 21Star Combo Pharma's (ASX:S66) Robust Earnings Might Be Weaker Than You Think
Mar 02Rock star Growth Puts Star Combo Pharma (ASX:S66) In A Position To Use Debt
Dec 24CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Dec 31 2023 | n/a | n/a | AU$485k |
Sep 30 2023 | n/a | n/a | -AU$2m |
Jun 30 2023 | AU$196k | AU$170k | -AU$4m |
Mar 31 2023 | n/a | n/a | -AU$5m |
Dec 31 2022 | n/a | n/a | -AU$5m |
Sep 30 2022 | n/a | n/a | -AU$3m |
Jun 30 2022 | AU$194k | AU$172k | -AU$696k |
Mar 31 2022 | n/a | n/a | -AU$5m |
Dec 31 2021 | n/a | n/a | -AU$8m |
Sep 30 2021 | n/a | n/a | -AU$8m |
Jun 30 2021 | AU$182k | AU$163k | -AU$8m |
Mar 31 2021 | n/a | n/a | -AU$3m |
Dec 31 2020 | n/a | n/a | AU$1m |
Sep 30 2020 | n/a | n/a | AU$533k |
Jun 30 2020 | AU$169k | AU$153k | -AU$349k |
Mar 31 2020 | n/a | n/a | -AU$990k |
Dec 31 2019 | n/a | n/a | -AU$2m |
Sep 30 2019 | n/a | n/a | -AU$2m |
Jun 30 2019 | AU$164k | AU$150k | -AU$2m |
Mar 31 2019 | n/a | n/a | -AU$2m |
Dec 31 2018 | n/a | n/a | -AU$3m |
Sep 30 2018 | n/a | n/a | -AU$2m |
Jun 30 2018 | AU$93k | AU$85k | -AU$2m |
Jun 30 2017 | AU$66k | AU$60k | AU$2m |
Compensation vs Market: Su's total compensation ($USD128.35K) is below average for companies of similar size in the Australian market ($USD292.50K).
Compensation vs Earnings: Su's compensation has been consistent with company performance over the past year.
CEO
Su Zhang
6.2yrs
Tenure
AU$196,318
Compensation
Ms. Su Zhang, MBA, GradCertComm, BPharm serves as Chief Executive Officer at Star Combo Pharma Ltd since November 2018 and serves as its Executive Director since 2018. She served as Director at Star Combo...
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO & Executive Director | 6.2yrs | AU$196.32k | 8.48% A$ 1.3m | |
Founder | 7.3yrs | AU$198.93k | 28.25% A$ 4.4m | |
Independent Non-Executive Chairman | 6.1yrs | AU$100.91k | no data | |
Non Executive Director | 3.8yrs | no data | no data | |
Non Executive Director | 3.8yrs | no data | no data |
6.1yrs
Average Tenure
Experienced Board: S66's board of directors are considered experienced (6.1 years average tenure).